Multicentre Study To Evaluate Efficacy And Safety Of Buprenorphine Transdermal Patch (Norspan) In Chronic Non-Malignant Pain Of Moderate To Severe Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint / Muscle Pain, When Opioid Is Needed For Analgesia

Trial Profile

Multicentre Study To Evaluate Efficacy And Safety Of Buprenorphine Transdermal Patch (Norspan) In Chronic Non-Malignant Pain Of Moderate To Severe Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint / Muscle Pain, When Opioid Is Needed For Analgesia

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Back pain; Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Mundipharma International
  • Most Recent Events

    • 16 Aug 2016 Last checked against China Clinical Trials Register record.
    • 14 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 10 Apr 2014 New source identified and integrated, China Clinical Trials Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top